• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微小RNA-595通过靶向ABCB1使卵巢癌细胞对顺铂敏感。

MicroRNA-595 sensitizes ovarian cancer cells to cisplatin by targeting ABCB1.

作者信息

Tian Songyu, Zhang Mingyue, Chen Xiuwei, Liu Yunduo, Lou Ge

机构信息

Department of Gynecology Oncology, Cancer Hospital of Harbin Medical University, Harin, 150081, Heilongjiang, China.

Department of Anaesthesiology, Cancer Hospital of Harbin Medical University, Harin, 150081, Heilongjiang, China.

出版信息

Oncotarget. 2016 Dec 27;7(52):87091-87099. doi: 10.18632/oncotarget.13526.

DOI:10.18632/oncotarget.13526
PMID:27893429
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5349973/
Abstract

Ovarian cancer is among the leading cause of cancer-related deaths in females. In this study, we demonstrated that miR-595 expression was downregulated in the ovarian cancer tissues and cell lines. miR-595 expression was lower in the lymph node metastases tissues than in the primary ovarian cancer tissues and normal tissues. Furthermore, miR-595 overexpression suppressed the ovarian cancer cell proliferation, colony formation and invasion and promoted the sensitivity of ovarian cancer cell to cisplatin. We identified ABCB1 as a direct target gene of miR-595 in the ovarian cancer cell. ABCB1 expression was upregulated in the ovarian cancer tissues and cell lines. Morevoer, the expression level of ABCB1 was inversely correlated with miR-595 in the ovarian cancer tissues. In addition, overexpression of ABCB1 decreased the miR-595-overexpressing HO8910PM and SKOV-3 cell sensitivity to cisplatin. Ectopic expression of ABCB1 promoted the miR-595-overexpressing HO8910PM and SKOV-3 cell proliferation, colony formation and invasion. These data suggested that miR-595 acted a tumor suppressor role in ovarian cancer development and increased the sensitivity of ovarian cancer to cisplatin.

摘要

卵巢癌是女性癌症相关死亡的主要原因之一。在本研究中,我们证明miR-595在卵巢癌组织和细胞系中的表达下调。miR-595在淋巴结转移组织中的表达低于原发性卵巢癌组织和正常组织。此外,miR-595过表达抑制卵巢癌细胞增殖、集落形成和侵袭,并提高卵巢癌细胞对顺铂的敏感性。我们确定ABCB1是卵巢癌细胞中miR-595的直接靶基因。ABCB1在卵巢癌组织和细胞系中的表达上调。此外,在卵巢癌组织中ABCB1的表达水平与miR-595呈负相关。另外,ABCB1过表达降低了miR-595过表达的HO8910PM和SKOV-3细胞对顺铂的敏感性。ABCB1的异位表达促进了miR-595过表达的HO8910PM和SKOV-3细胞的增殖、集落形成和侵袭。这些数据表明miR-595在卵巢癌发展中起肿瘤抑制作用,并增加了卵巢癌对顺铂的敏感性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6d0/5349973/44d7389c890f/oncotarget-07-87091-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6d0/5349973/ec5fe1f29c6c/oncotarget-07-87091-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6d0/5349973/c4d82790d4d6/oncotarget-07-87091-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6d0/5349973/06a6f49c3a1f/oncotarget-07-87091-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6d0/5349973/29039253f87b/oncotarget-07-87091-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6d0/5349973/7217485a5eb8/oncotarget-07-87091-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6d0/5349973/44d7389c890f/oncotarget-07-87091-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6d0/5349973/ec5fe1f29c6c/oncotarget-07-87091-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6d0/5349973/c4d82790d4d6/oncotarget-07-87091-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6d0/5349973/06a6f49c3a1f/oncotarget-07-87091-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6d0/5349973/29039253f87b/oncotarget-07-87091-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6d0/5349973/7217485a5eb8/oncotarget-07-87091-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6d0/5349973/44d7389c890f/oncotarget-07-87091-g006.jpg

相似文献

1
MicroRNA-595 sensitizes ovarian cancer cells to cisplatin by targeting ABCB1.微小RNA-595通过靶向ABCB1使卵巢癌细胞对顺铂敏感。
Oncotarget. 2016 Dec 27;7(52):87091-87099. doi: 10.18632/oncotarget.13526.
2
MicroRNA-186 induces sensitivity of ovarian cancer cells to paclitaxel and cisplatin by targeting ABCB1.微小RNA-186通过靶向ABCB1诱导卵巢癌细胞对紫杉醇和顺铂的敏感性。
J Ovarian Res. 2015 Dec 2;8:80. doi: 10.1186/s13048-015-0207-6.
3
MicroRNA-133b targets glutathione S-transferase π expression to increase ovarian cancer cell sensitivity to chemotherapy drugs.微小RNA-133b靶向谷胱甘肽S-转移酶π的表达以增加卵巢癌细胞对化疗药物的敏感性。
Drug Des Devel Ther. 2015 Sep 16;9:5225-35. doi: 10.2147/DDDT.S87526. eCollection 2015.
4
MicroRNA-873 mediates multidrug resistance in ovarian cancer cells by targeting ABCB1.微小RNA-873通过靶向ABCB1介导卵巢癌细胞的多药耐药性。
Tumour Biol. 2016 Aug;37(8):10499-506. doi: 10.1007/s13277-016-4944-y. Epub 2016 Feb 5.
5
MiR-497 decreases cisplatin resistance in ovarian cancer cells by targeting mTOR/P70S6K1.微小RNA-497通过靶向雷帕霉素靶蛋白/核糖体蛋白S6激酶1降低卵巢癌细胞对顺铂的耐药性。
Oncotarget. 2015 Sep 22;6(28):26457-71. doi: 10.18632/oncotarget.4762.
6
MiR-514 attenuates proliferation and increases chemoresistance by targeting ATP binding cassette subfamily in ovarian cancer.miR-514 通过靶向 ABC 转运子家族抑制卵巢癌细胞增殖并增加化疗耐药性
Mol Genet Genomics. 2018 Oct;293(5):1159-1167. doi: 10.1007/s00438-018-1447-0. Epub 2018 May 11.
7
MiR-1294 confers cisplatin resistance in ovarian Cancer cells by targeting IGF1R.miR-1294 通过靶向 IGF1R 赋予卵巢癌细胞顺铂耐药性。
Biomed Pharmacother. 2018 Oct;106:1357-1363. doi: 10.1016/j.biopha.2018.07.059. Epub 2018 Jul 23.
8
Targeting miR-21-3p inhibits proliferation and invasion of ovarian cancer cells.靶向miR-21-3p可抑制卵巢癌细胞的增殖和侵袭。
Oncotarget. 2016 Jun 14;7(24):36321-36337. doi: 10.18632/oncotarget.9216.
9
MircroRNA-139 sensitizes ovarian cancer cell to cisplatin-based chemotherapy through regulation of ATP7A/B.miR-139 通过调控 ATP7A/B 使卵巢癌细胞对顺铂为基础的化疗敏感。
Cancer Chemother Pharmacol. 2018 May;81(5):935-947. doi: 10.1007/s00280-018-3548-1. Epub 2018 Mar 28.
10
STAT3 regulated promotes ovarian cancer proliferation and cisplatin resistance.STAT3 调控促进卵巢癌细胞增殖和顺铂耐药性。
Biosci Rep. 2018 Aug 29;38(4). doi: 10.1042/BSR20180547. Print 2018 Aug 31.

引用本文的文献

1
miR‑145 and miR‑23b co‑transfection decreases proliferation, migration, invasion and protein levels of c‑MYC, ZEB1 and ABCB1 in epithelial ovarian cancer cell lines.miR-145和miR-23b共转染可降低上皮性卵巢癌细胞系中c-MYC、ZEB1和ABCB1的增殖、迁移、侵袭及蛋白水平。
Mol Med Rep. 2025 Sep;32(3). doi: 10.3892/mmr.2025.13611. Epub 2025 Jul 11.
2
MiRNAs: main players of cancer drug resistance target ABC transporters.微小RNA:癌症耐药性的主要作用靶点是ABC转运蛋白。
Naunyn Schmiedebergs Arch Pharmacol. 2025 Jan 14. doi: 10.1007/s00210-024-03719-y.
3
Hsa_circ_0109320 Serves as a Novel Circular RNA Biomarker in Non-small Cell Lung Cancer by Promoting Metastasis.

本文引用的文献

1
RPL27A is a target of miR-595 and may contribute to the myelodysplastic phenotype through ribosomal dysgenesis.RPL27A是miR-595的一个靶点,可能通过核糖体发育异常导致骨髓增生异常表型。
Oncotarget. 2016 Jul 26;7(30):47875-47890. doi: 10.18632/oncotarget.10293.
2
ABCB1 polymorphism is associated with atorvastatin-induced liver injury in Japanese population.ABCB1基因多态性与日本人群中阿托伐他汀所致肝损伤有关。
BMC Genet. 2016 Jun 13;17(1):79. doi: 10.1186/s12863-016-0390-5.
3
Relationship between ABCB1 polymorphisms and serum methadone concentration in patients undergoing methadone maintenance therapy (MMT).
Hsa_circ_0109320通过促进转移,作为非小细胞肺癌中的一种新型环状RNA生物标志物。
Mol Biotechnol. 2024 Nov 5. doi: 10.1007/s12033-024-01306-3.
4
MicroRNA as a Potential Therapeutic Molecule in Cancer.微小 RNA 作为癌症治疗的潜在分子
Cells. 2022 Mar 16;11(6):1008. doi: 10.3390/cells11061008.
5
MicroRNAs as the critical regulators of Cisplatin resistance in ovarian cancer cells.MicroRNAs 作为卵巢癌细胞顺铂耐药的关键调节因子。
J Ovarian Res. 2021 Sep 30;14(1):127. doi: 10.1186/s13048-021-00882-1.
6
circ_NRIP1 is oncogenic in malignant development of esophageal squamous cell carcinoma (ESCC) via miR-595/SEMA4D axis and PI3K/AKT pathway.环状核糖核酸NRIP1通过miR-595/SEMA4D轴和PI3K/AKT途径在食管鳞状细胞癌(ESCC)的恶性发展中发挥致癌作用。
Cancer Cell Int. 2021 May 6;21(1):250. doi: 10.1186/s12935-021-01907-x.
7
Suppression of Circular RNA Hsa_circ_0109320 Attenuates Non-Small Cell Lung Cancer Progression via MiR-595/E2F7 Axis.环状 RNA Hsa_circ_0109320 通过 miR-595/E2F7 轴抑制非小细胞肺癌进展。
Med Sci Monit. 2020 Jun 8;26:e921200. doi: 10.12659/MSM.921200.
8
The long non-coding RNA LINC00473 contributes to cell proliferation via JAK-STAT3 signaling pathway by regulating miR-195-5p/SEPT2 axis in prostate cancer.长链非编码 RNA LINC00473 通过调节 miR-195-5p/SEPT2 轴在前列腺癌中通过 JAK-STAT3 信号通路促进细胞增殖。
Biosci Rep. 2020 Sep 30;40(9). doi: 10.1042/BSR20191850.
9
MicroRNA-153 regulated AKT1 expression and suppressed cell proliferation of epithelial ovarian cancer cells.微小RNA-153调节AKT1表达并抑制上皮性卵巢癌细胞的增殖。
Int J Clin Exp Pathol. 2017 Jul 1;10(7):7417-7426. eCollection 2017.
10
Role of microRNAs as Clinical Cancer Biomarkers for Ovarian Cancer: A Short Overview.miRNAs 作为卵巢癌临床癌症生物标志物的作用:简要概述。
Cells. 2020 Jan 9;9(1):169. doi: 10.3390/cells9010169.
美沙酮维持治疗(MMT)患者中ABCB1基因多态性与血清美沙酮浓度的关系。
Am J Drug Alcohol Abuse. 2016 Sep;42(5):587-596. doi: 10.3109/00952990.2016.1172078. Epub 2016 Jun 10.
4
Ferulic acid reverses ABCB1-mediated paclitaxel resistance in MDR cell lines.阿魏酸可逆转多药耐药细胞系中ABCB1介导的紫杉醇耐药性。
Eur J Pharmacol. 2016 Sep 5;786:194-203. doi: 10.1016/j.ejphar.2016.05.023. Epub 2016 Jun 1.
5
Influence of ABCB1 and ABCG2 polymorphisms on the antiemetic efficacy in patients with cancer receiving cisplatin-based chemotherapy: a TRIPLE pharmacogenomics study.ABCB1和ABCG2基因多态性对接受顺铂化疗的癌症患者止吐疗效的影响:一项TRIPLE药物基因组学研究。
Pharmacogenomics J. 2017 Oct;17(5):435-440. doi: 10.1038/tpj.2016.38. Epub 2016 May 31.
6
MiR-595 targeting regulation of SOX7 expression promoted cell proliferation of human glioblastoma.miR-595 通过靶向调控 SOX7 的表达促进人脑胶质瘤细胞的增殖。
Biomed Pharmacother. 2016 May;80:121-126. doi: 10.1016/j.biopha.2016.03.008. Epub 2016 Mar 19.
7
Pilot PET Study to Assess the Functional Interplay Between ABCB1 and ABCG2 at the Human Blood-Brain Barrier.评估人类血脑屏障中ABCB1与ABCG2之间功能相互作用的PET初步研究。
Clin Pharmacol Ther. 2016 Aug;100(2):131-41. doi: 10.1002/cpt.362. Epub 2016 May 9.
8
ABCG2 and ABCB1 Limit the Efficacy of Dasatinib in a PDGF-B-Driven Brainstem Glioma Model.ABCG2和ABCB1限制达沙替尼在血小板衍生生长因子B驱动的脑干胶质瘤模型中的疗效。
Mol Cancer Ther. 2016 May;15(5):819-29. doi: 10.1158/1535-7163.MCT-15-0093. Epub 2016 Feb 16.
9
MicroRNA-873 mediates multidrug resistance in ovarian cancer cells by targeting ABCB1.微小RNA-873通过靶向ABCB1介导卵巢癌细胞的多药耐药性。
Tumour Biol. 2016 Aug;37(8):10499-506. doi: 10.1007/s13277-016-4944-y. Epub 2016 Feb 5.
10
Circulating microRNAs, miR-939, miR-595, miR-519d and miR-494, Identify Cirrhotic Patients with HCC.循环微RNA,即miR-939、miR-595、miR-519d和miR-494,可识别肝硬化合并肝癌患者。
PLoS One. 2015 Oct 28;10(10):e0141448. doi: 10.1371/journal.pone.0141448. eCollection 2015.